Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?

BACKGROUND: Annual MRI screening is associated with a significant reduction in advanced-stage breast cancer diagnosis in BRCA1/2 mutation carriers. The impact that early detection has on subsequent oncological treatment is less frequently reported. In this study we compared disease stage and therape...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Breast
Egile Nagusiak: Bernstein-Molho, Rinat, Kaufman, Bella, Ben David, Merav A., Sklair-Levy, Miri, Feldman, Dana Madoursky, Zippel, Dov, Laitman, Yael, Friedman, Eitan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7375664/
https://ncbi.nlm.nih.gov/pubmed/31760168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2019.10.012
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak